A look at care in the last months of life with glioblastoma
Original title: Potentially inappropriate care at the end of life in patients with glioblastoma: A single-center observational cohort study.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
Doctors looked back at care people already got. It was not a test of a new treatment.
The short version
About 1 in 5 people with this brain tumor got care near the end of life that may not have helped them.
What was studied. Doctors at one hospital looked back at records for 310 people who died of glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary. They checked what care each person got in the last 3 months of life.
What they found. 22% of them, 67 of 310, got care that may not have helped. Chemotherapy was the main one, in 58 of 67 people. Two or more hospital stays showed up in 10 of 67, and 9 of 67 died in the hospital.
What this means, and what it doesn't
What it could mean: It may help to talk with your team early about comfort care. You can ask if a treatment is likely to help you feel better. You can also ask what it would mean to stop.
What it doesn't mean: This does not mean chemotherapy is wrong for you. It was one hospital looking back at old records. It did not test a new treatment, and nothing here changes care today. It is not a promise of a cure.
Source: PubMed, September 23, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.